Follow @TheHPRA
Contact us
As Gaeilge
My HPRA:
Login
Register
About Us
Medicines
Veterinary
Medical Devices
Cosmetics
Controlled Substances
Blood, Tissues, Organs
Medicines
Safety Notices
My HPRA:
Login
Register
About Us
Medicines
COVID-19 vaccines and treatments
Our Role
Medicines Information
Safety Information
Safety Notices
Quality Information
Regulatory Information
News & Events
Special Topics
Emergency Medicines
Emergency Contact Details
Veterinary
Medical Devices
Cosmetics
Controlled Substances
Blood, Tissues, Organs
Gilenya (fingolimod) - Important Safety Information from Novartis Ireland Ltd
Notice type:
3rd Party Publications
Date:
26/08/2019
Problem Or Issue:
Important Safety Information from Novartis Ireland Ltd on new contraindication in pregnant women and in women of childbearing potential not using effective contraception - Gilenya (fingolimod)
Important Safety Information - Gilenya (fingolimod)
« Back
Date Printed: 20/04/2024